Skip to main content
    K

    Kymera Therapeutics Inc (KYMR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $121.52
    -4.33 (-3.44%)

    Market Cap: $10.74B

    Last updated: Nov 17, 2026 at 4:35 PM ET

    Kymera Therapeutics Inc (KYMR) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Kymera Therapeutics (KYMR) has a latest price of $121.52 on Nov 17, 2026, 15.0% below its 52-week high of $142.92. Its price rose 87.1% over the past 12 months. The month-end price rose 115.1% over the 5 years through Oct 2026, a compound annual rate of 16.6%.

    Price Chart

    From Aug 2020 to Oct 2026, its highest month-end close was $126.63 in Oct 2026 and its lowest $11.67 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart KYMR with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KYMR.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 4.5%, and over 6 months it rose 55.5%. The month-end price rose 985.1% over the 3 years through Oct 2026, a compound annual rate of 121.4%.

    PeriodChange
    1 month+12.4%
    3 months-4.5%
    6 months+55.5%
    12 months+87.1%
    12 months, with dividends+87.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+985.1%+121.4%
    5 years+115.1%+16.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 93.4%, and its weakest was 2022, when it fell 60.7%.

    YearCloseChange
    2026 through Oct 2026$126.63+62.7%
    2025$77.81+93.4%
    2024$40.23+58.0%
    2023$25.46+2.0%
    2022$24.96-60.7%
    2021$63.49+2.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 3.5% above its 50-day average of $117.40 and 21.6% above its 200-day average of $99.94.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$121.52
    52-week high$142.92-15.0%
    52-week low$63.69+90.8%
    50-day average$117.40+3.5%
    200-day average$99.94+21.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 59.8%.

    MeasureValue
    1-year beta0.95
    Largest fall, 1 year-27.7%
    Largest fall, 3 years-59.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About KYMR

    What is KYMR's 1-year price change?

    Kymera Therapeutics's price rose 87.1% over the past 12 months. With dividends included, the 12-month total return was 87.1%.

    What is KYMR's 5-year price change?

    Kymera Therapeutics's month-end price rose 115.1% over the 5 years through Oct 2026, a compound annual rate of 16.6%. These figures leave out dividends.

    What is KYMR's 52-week high and low?

    Kymera Therapeutics's 52-week high is $142.92 and its 52-week low is $63.69. Its latest price of $121.52 on Nov 17, 2026 is 15.0% below the high.

    What is KYMR's beta?

    Kymera Therapeutics's 1-year beta against the S&P 500 is 0.95, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 27.7%.

    Is the KYMR chart free?

    Yes. Advanced Charting for KYMR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.